BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bannik K, Madas B, Jarzombek M, Sutter A, Siemeister G, Mumberg D, Zitzmann-Kolbe S. Radiobiological effects of the alpha emitter Ra-223 on tumor cells. Sci Rep 2019;9:18489. [PMID: 31811257 DOI: 10.1038/s41598-019-54884-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Filippi L, Chiaravalloti A, Schillaci O, Bagni O. The potential of PSMA-targeted alpha therapy in the management of prostate cancer. Expert Rev Anticancer Ther 2020;20:823-9. [PMID: 32820953 DOI: 10.1080/14737140.2020.1814151] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
2 Bastiani I, McMahon SJ, Turner P, Redmond KM, McGarry CK, Cole A, O'Sullivan JM, Prise KM, Ainsbury L, Anderson R. Dose estimation after a mixed field exposure: Radium-223 and intensity modulated radiotherapy. Nucl Med Biol 2021;106-107:10-20. [PMID: 34968973 DOI: 10.1016/j.nucmedbio.2021.12.002] [Reference Citation Analysis]
3 King AP, Lin FI, Escorcia FE. Why bother with alpha particles? Eur J Nucl Med Mol Imaging 2021. [PMID: 34175980 DOI: 10.1007/s00259-021-05431-y] [Reference Citation Analysis]
4 Guerra Liberal FDC, O'Sullivan JM, McMahon SJ, Prise KM. Targeted Alpha Therapy: Current Clinical Applications. Cancer Biother Radiopharm 2020;35:404-17. [PMID: 32552031 DOI: 10.1089/cbr.2020.3576] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
5 Gongora ABL, Marshall CH, Velho PI, Lopes CDH, Marin JF, Camargo AA, Bastos DA, Antonarakis ES. Extreme Responses to a Combination of DNA-Damaging Therapy and Immunotherapy in CDK12-Altered Metastatic Castration-Resistant Prostate Cancer: A Potential Therapeutic Vulnerability. Clin Genitourin Cancer 2021:S1558-7673(21)00245-7. [PMID: 35027313 DOI: 10.1016/j.clgc.2021.11.015] [Reference Citation Analysis]
6 Bannik K, Madas B, Jarke S, Sutter A, Siemeister G, Schatz C, Mumberg D, Zitzmann-Kolbe S. DNA repair inhibitors sensitize cells differently to high and low LET radiation. Sci Rep 2021;11:23257. [PMID: 34853427 DOI: 10.1038/s41598-021-02719-9] [Reference Citation Analysis]
7 Schumann S, Eberlein U, Lapa C, Müller J, Serfling S, Lassmann M, Scherthan H. α-Particle-induced DNA damage tracks in peripheral blood mononuclear cells of [223Ra]RaCl2-treated prostate cancer patients. Eur J Nucl Med Mol Imaging 2021;48:2761-70. [PMID: 33537837 DOI: 10.1007/s00259-020-05170-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Guerra Liberal F, McMahon SJ, Prise KM. TOPAS a tool to evaluate the impact of cell geometry and radionuclide on alpha particle therapy. Biomed Phys Eng Express 2021. [PMID: 33770769 DOI: 10.1088/2057-1976/abf29f] [Reference Citation Analysis]